PRESS RELEASE published on 03/16/2026 at 09:35, 6 months 19 days ago Franchissements de seuils Déclaration de franchissements de seuils par J.P. Morgan Chase & Co. concernant Inventiva, société cotée sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuils Inventiva J.P. Morgan Chase & Co.
BRIEF published on 03/12/2026 at 15:56, 6 months 22 days ago Threshold Crossing at Inventiva Actions Stock Market Crossing Thresholds JP Morgan Chase & Co. Inventiva
BRIEF published on 03/12/2026 at 15:56, 6 months 22 days ago Franchissement de Seuils chez Inventiva Actions Franchissement De Seuils Marché Boursier Inventiva J.P. Morgan Chase & Co.
PRESS RELEASE published on 03/12/2026 at 15:51, 6 months 22 days ago Franchissement e seuils Déclaration de franchissement de seuils par J.P. Morgan Chase & Co. pour INVENTIVA le 5 mars 2026 Déclaration AMF Franchissement De Seuils Inventiva J.P. Morgan Chase & Co.
BRIEF published on 02/17/2026 at 14:32, 7 months 14 days ago Franchissement de Seuil par Deep Track Biotechnology Droits De Vote Franchissement De Seuil Actions Inventiva Deep Track
BRIEF published on 02/17/2026 at 14:32, 7 months 14 days ago Threshold Crossing by Deep Track Biotechnology Voting Rights Actions Threshold Crossing Inventiva Deep Track
PRESS RELEASE published on 02/17/2026 at 14:27, 7 months 14 days ago Franchissement de seuil Déclaration de franchissement de seuil de 5% des droits de vote d'INVENTIVA par Deep Track Biotechnology Master Fund, Ltd. pour compte de fonds gérés Franchissement De Seuil Cession D'actions Inventiva Deep Track Biotechnology Master Fund 5%
BRIEF published on 02/17/2026 at 08:35, 7 months 15 days ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
BRIEF published on 02/17/2026 at 08:35, 7 months 15 days ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
BRIEF published on 02/17/2026 at 08:35, 7 months 15 days ago Inventiva publie ses résultats financiers préliminaires pour 2025 Résultats Financiers Produits Biopharmaceutiques Des Flux De Trésorerie Inventive ÉCRASER
Published on 10/02/2026 at 13:50, 1 day 19 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 20 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 20 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 3 hours 43 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 4 hours 33 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 18 hours 4 minutes ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 9 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 13 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 1 day 16 hours ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 16 hours ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 16 hours ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 16 hours ago Aéroports de Paris SA - Calendrier financier 2027
